Human Albumin Takeda

Restoration & maintenance of circulating blood vol where vol deficiency has been demonstrated, & use of a colloid is appropriate.

IV Required dose depends on size of patient, severity of trauma or illness, & continuing fluid & protein losses. Adjust infusion rate according to individual circumstances & indication.

Hypersensitivity to albumin prep or any of the excipients.

Suspicion of allergic or anaphylactic type reactions requires immediate discontinuation. Use w/ caution in conditions where hypervolaemia & its consequences or haemodilution could represent a special risk for the patient. Ensure adequate hydration when concentrated albumin is administered, & carefully monitor to guard against circulatory overload & hyperhydration. Monitor electrolyte status & restore or maintain electrolyte balance. Must not be diluted w/ water for inj as this may cause haemolysis in recipients. Control coagulation & haematocrit if comparatively large vol are to be replaced. Hypervolaemia may occur if dosage & infusion rate are not adjusted to patient's circulatory situation. Immediately stop infusion at the 1st clinical signs of CV overload, or increased BP, raised central venous pressure & pulmonary oedema. Possibility of transmitting infective agents cannot be totally excluded when medicinal products prepared from human blood or plasma are administered. 20%: Contains 115-149.5 mg Na per vial, equiv to 5.8-7.5% of WHO-recommended max daily intake of 2 g Na for an adult. 25%: Contains 149.5-184 mg Na per vial, equiv to 7.5-9.2% of WHO-recommended max daily intake of 2 g Na for an adult.

Rare: Nausea, flushing, skin rash, fever.

Intravenous & Other Sterile Solutions

B05AA01 - albumin ; Belongs to the class of blood substitutes and plasma protein fractions. Used as blood substitutes.

P₁S₁S₃